三唑类抗肿瘤药物的研究进展
作者：米佳丽;吴俊;周成合;
Author：
收稿日期： 年卷（期）页码：2008,(01):-84-86
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：药物化学;抗肿瘤;三唑;芳香化酶抑制剂;抗血管生成
Key words：
基金项目：人事部回国人员重点项目(2002-99);;
重庆市自然科学基金(2007BB5369);;
西南大学人才引进基金资助(SWUB2006018)
中文摘要
综述了三唑类化合物作为芳香化酶抑制剂、CYP26A1和CYP1A抑制剂、蛋白激酶抑制剂、碳酸酐酶抑制剂、血管生成抑制剂、微管蛋白聚合抑制剂和法呢基转移酶抑制剂等多个抗肿瘤领域的研究开发现状。
参考文献
[1]Avendano C,Menendez J.Inhibitors of multidrug resistance toantitumor agents(MDR)[J].Current medicinal chemistry,2002,9(2):159-193.
[2]Yahiaoui S,Pouget C,Fagnere C,et al.Synthesis and evaluationof 4-triazolylflavans as new aromatase inhibitors[J].BioorgMed Chem Lett,2004,14(20):5215-5218.
[3]Demirba N,Ugurluoglu R.Synthesis of novel 4-alkylidene-and 4-alkylamino-5-oxo-4,5-dihydro-[1,2,4]triazolederivatives and investigation of their antitumor activities[J].Turk J Chem,2004,28(5):559-571.
[4]Hackett JC,Kim YW,Su B,et al.Synthesis and characteriza-tion of azole isoflavone inhibitors of aromatase[J].Bioorg MedChem,2005,13(12):4063-4070.
[5]Saberi MR,Vinh TK,Yee SW,et al.Potent CYP19(Aro-matase)1-[(Benzofuran-2-yl)(phenylmethyl)pyridine,-imidazole,and-triazole Inhibitors:synthesis and biologicalevaluation[J].J Med Chem,2006,49(3):1016-1022.
[6]Pautus S,Yee SW,Jayne M,et al.Synthesis and CYP26A1 in-hibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles[J].Bioorg Med Chem,2006,14(11):3643-3653.
[7]Yang B,He QJ,Zhu DY,et al.Antiproliferative activity of cont-ragestazol(DL111-IT)in murine and human tumor models invitro and in vivo[J].Canc Chemother Pharm,2006,57(2):268-273.
[8]Sarno S,Salvi M,Battistutta R,et al.Features and potentials ofATP-site directed CK2 inhibitors[J].Biochim Biophys Acta,2005,1754(1-2):263-270.
[9]Lin R,Connolly PJ,Huang S,et al.1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancercyclin-dependent kinase inhibitors:synthesis and evaluation ofbiological activities[J].J Med Chem,2005,48(13):4208-4211.
[10]Lloyd MD,Thiyagarajan N,Ho YT,et al.First crystal structuresof human carbonic anhydrase ii in complex with dual aroma-tase———steroid sulfatase inhibitors[J].Biochem,2005,44(18):6858-6866.
[11]Dutcher JP,Leon L,Manola J,et al.Phase II study of carboxy-amidotriazole in patients with advanced renal cell carcinoma re-fractory to immunotherapy:E4896,an Eastern Cooperative On-cology Group Study[J].Cancer,2005,104(11):2392-2399.
[12]Cruysberg LP,Franklin AJ,Sanders J,et al.Effective transs-cleral delivery of two retinal anti-angiogenic molecules:car-boxyamido-triazole(CAI)and 2-methoxyestradiol(2ME2)[J].Retina,2005,25(8):1022-1031.
[13]Kallander LS,Lu Q,Chen W,et al.4-Aryl-1,2,3-triazole:a novel template for a reversible methionine aminopeptidase 2 in-hibitor,optimized to inhibit angiogenesis in vivo[J].J MedChem,2005,48(18):5644-5647.
[14]Ouyang XH,Chen XL,Piatnitski EL,et al.Synthesis and struc-ture-activity relationships of1,2,4-triazoles as a novel class ofpotent tubulin polymerization inhibitors[J].Bioorg Med ChemLett,2005,15(23):5154-5159.
[15]Saha AK,Liu L,SimoneauxR,et al.Novel triazole based inhib-itors of Ras farnesyl transferase[J].Bioorg Med Chem Lett,2005,15(24):5407-5411.
[16]Fang LY,Zhang GS,Li CL,et al.Discovery of a daunorubicinanalogue that exhibits potent antitumor activity and overcomesP-gp-mediated drug resistance[J].J Med Chem,2006,49(3):932-941.
[17]Francesca G,Franchi-Gazzola R,Lanfranchi M,et al.Synthe-sis,solution equilibria and antiproliferative activity of copper(II)aminomethyltriazole and aminomethyl thioxotriazoline complexes[J].J Inorg Biochem,2005,99(8):1573-1584.
[18]Tian LJ,Sun YX,Li HJ,et al.Synthesis,characterization andbiological activity of triorganotin 2-phenyl-1,2,3-triazole-4-carboxylates[J].J Inorg Biochem,2005,99(8):1646-1652.
[19]Lemke K,Wojciechowski M,Laine W,et al.Induction of u-nique structural changes in guanine-rich DNAregions by the tri-azoloacridone C-1305,a topoisomerase II inhibitor with antitu-mor activities[J].Nucleic Acids Res,2005,33(18):6034-6047.
[20]Bekircan O,Küxük M,Kahveci B,et al.Convenient synthesis offused heterocyclic 1,3,5-triazines from some N-acyl imidatesand heterocyclic amines as anticancer and antioxidant agents[J].Arch Pharm Chem Life Sci,2005,338(8):365-372.
【关闭】
